HUMAN TB

Conventional phase 3 trials do not provide key information about the overall effect of introducing a new tuberculosis vaccine programme and so are missing crucial information for policy makers, argue experts in a personal view in Lancet Microbe.

Actiphage TB is to enter its third clinical trial, which is aimed at validating its utility as a tuberculosis diagnostic. The phage-based diagnostic has potential for detecting TB progression.

The bacteriophage-based diagnostic may play vital role in detecting TB progression

Without treatment 1 in 10 people with latent TB will progress to active TB but how can they be identified?

Accurate and rapid drug resistance testing is essential for early diagnosis of both drug-sensitive and drug-resistant TB.

We embrace the World TB day theme 'Yes! We Can End TB' with an educational webinar event on new diagnostic tests that are urgently needed to screen LTBI and determine who will progress to active TB disease.

The role of phage-based laboratory diagnostics in the detection of tuberculosis is to be discussed in a live webinar hosted by the AACC, it has been announced ahead of World TB Day.

Creating a shared language for talking about tuberculosis has been identified by the Stop TB Partnership as being a constructive step towards achieving the United Nations political declaration to eliminate TB by 2030.